Demant A/S Unsponsored ADR (OTCMKTS:WILYY – Get Free Report) gapped up before the market opened on Wednesday . The stock had previously closed at $18.30, but opened at $19.40. Demant A/S shares last traded at $19.40, with a volume of 2,003 shares trading hands.
Analyst Upgrades and Downgrades
Separately, Jefferies Financial Group upgraded shares of Demant A/S from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, March 18th. Two research analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, Demant A/S has a consensus rating of “Buy”.
Check Out Our Latest Report on WILYY
Demant A/S Stock Up 4.4%
Demant A/S Company Profile
Demant A/S is a Denmark-based global hearing health care company specializing in the development, manufacture and distribution of hearing solutions and audiological diagnostic instruments. The company’s flagship brands include Oticon, Bernafon and Sonic, which offer a range of hearing aids designed to address various levels of hearing loss. In addition to personal hearing devices, Demant provides diagnostic equipment such as audiometers and tympanometers, supporting hearing care professionals in accurate assessment and fitting of hearing solutions.
Beyond hearing aids and diagnostics, Demant’s product portfolio extends to hearing implants—cochlear and bone-anchored systems—through its Oticon Medical division.
Further Reading
- Five stocks we like better than Demant A/S
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Receive News & Ratings for Demant A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Demant A/S and related companies with MarketBeat.com's FREE daily email newsletter.
